listing requirements

TNL Mediagene has secured continued listing on The Nasdaq Capital Market, contingent on meeting bid price requirements by January 7, 2026, following a successful appeal. This Asia-focused digital media conglomerate, formed from a merger of The News Lens and Mediagene Inc., offers diverse content and AI-driven advertising services. The company is implementing a reverse stock split to comply with Nasdaq’s $1 bid price rule.

Portage Biotech Inc. (PRTG) announced its continued listing compliance on the Nasdaq Capital Market, as confirmed by the Nasdaq. The immuno-oncology firm focuses on developing novel biologics to harness the immune system against cancer. This release contains forward-looking statements subject to risks and uncertainties, with actual results potentially differing from projections.